IDYA(IDEAYA Biosciences, Inc.) · 财务报表

IDYA(IDEAYA Biosciences, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$27.94M$50.93M$23.39M$7.00M$218.71M
毛利润—————
营业利润−$50.27M−$62.50M−$134.43M−$326.98M−$159.31M
净利润−$49.76M−$58.66M−$112.96M−$274.48M−$113.70M
经营现金流−$55.78M−$87.17M−$115.22M−$247.58M−$71.10M
自由现金流−$58.42M−$90.62M−$117.59M−$251.44M−$73.47M
摊薄每股收益$-1.41$-1.42$-1.96$-3.36$-1.28

IDEAYA Biosciences, Inc. IDYA